Heparin and Tenecteplase: Interaction Details

Same medicines, other forms
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Tenecteplase

We don't have a drug information page for Tenecteplase yet. Have a question about Tenecteplase? Ask a pharmacist, free →

What Happens When You Take Heparin With Tenecteplase

What can happen when they are taken together (rated Major)

An increased risk of bleeding

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Using an together with a fibrinolytic agent (eg, a thrombolytic) can raise the likelihood of major bleeding because the effects are .1 Two studies showed that a thrombolytic agent could be given safely alongside low-dose warfarin4 or low-intensity warfarin therapy (ie, an of 1.7 or lower).5

Still, when an anticoagulant must be combined with a fibrinolytic agent, patients should be observed clinically for signs and symptoms of external or internal bleeding, and laboratory monitoring is also recommended.2 Drainage from surgical wounds should be watched closely. A fall in Hb levels or a drop in blood pressure should raise suspicion of bleeding.3

The Heparin and Tenecteplase Interaction, Explained

Heparin is a that stops clots from growing. Tenecteplase is a clot-buster that breaks up clots that have already formed, often used in a heart attack or stroke. Both affect how your body handles clots, so together their effects add up and bleeding risk goes up. This is based on how the drugs work rather than on a specific study of this pair.

In the hospital, these are sometimes used together on purpose, and your care team watches closely for bleeding. Tell your nurse or doctor right away about any unusual bleeding, bruising, dizziness, or a bad headache. Your team can manage this safely.

Mechanism: effect. Heparin (indirect thrombin and factor Xa via antithrombin) plus tenecteplase (fibrin-specific plasminogen activator) impairs hemostasis by two routes. This is not a PK interaction, and status is not relevant. Direction: increased bleeding risk.

  • Severity: major. Evidence: theoretical. Onset: unspecified.
  • If is required, monitor for external bleeding and signs of internal bleeding.
  • Use clinical and laboratory monitoring (anticoagulation tests such as aPTT, PT), and measure Hb periodically.
  • Observe surgical wound drainage. A falling Hb or should prompt suspicion of bleeding.

See the 5 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Heparin and Tenecteplase Interact

The likely mechanism

effects

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Heparin and Tenecteplase Interaction

Care teams manage this by watching you closely rather than avoiding the combination when both are needed. Your team may monitor you more closely, and your dosing may be individualized.

  • Expect checks for bleeding, including surgical wound drainage if you've had surgery.
  • Blood tests, including clotting tests and hemoglobin levels, may be done periodically.
  • A drop in blood pressure or hemoglobin may prompt your team to look for bleeding.

Keep taking your medicines as prescribed. Report any bleeding, black stools, new pain, dizziness, or severe headache to your care team right away.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Heparin or Tenecteplase need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

3 reports from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: ANGIOMAX IV injection, bivalirudin IV injection

    In clinical trials of patients undergoing percutaneous transluminal coronary angioplasty (PTCA) or percutaneous coronary intervention (PCI), giving bivalirudin together with thrombolytic agents, glycoprotein IIb/IIIa , warfarin, or heparin was linked to a higher risk of major bleeding events than in patients who did not receive these medications.1 Any agent that may increase the risk of should be stopped before desirudin therapy is started.2

  2. Report 2 · Study title

    Streptokinase and concomitant oral anticoagulants in the treatment of deep venous thrombosis

    According to a Finnish study that assessed streptokinase combined with oral for the treatment of DVT, warfarin administration caused no problems, although lower doses were used during the streptokinase infusion. Forty-four patients first received warfarin 0.5 mg and streptokinase 600,000 international units.

    Streptokinase 600,000 international units/hour was continued for 3 days, and phlebography was done to assess clearing of the thrombotic occlusion. If lysis was incomplete, treatment was continued for another 3 days.

    When needed, warfarin was given to maintain a protein phosphatase (PP) activity level of 0.1 to 0.2. led to discontinuation of treatment in 8 of the 44 patients (18.2%).

    Although this study documents of oral anticoagulants and streptokinase, the anticoagulant and streptokinase were started at the same time. Because 3 to 5 days are needed before hypoprothrombinemia develops, these patients did not experience the true interaction, in which the thrombolytic effect of streptokinase occurs alongside hypoprothrombinemia caused by warfarin use.4

  3. Report 3 · Study title

    Safety of intravenous thrombolysis for ischemic stroke in patients treated with warfarin

    In a study analyzing registry data from 45,074 patients given IV tissue plasminogen activator for acute ischemic stroke, patients taking warfarin with an of 1.7 or less (n=768) had no significant increase in the risk of symptomatic intracerebral or death compared with patients not treated with warfarin (n=43,651), after adjustment for age, stroke severity, and comorbidities.5

Heparin and Tenecteplase: Common Questions

How serious is the Heparin and Tenecteplase interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Heparin and Tenecteplase interaction managed?

Care teams manage this by watching you closely rather than avoiding the combination when both are needed. Your team may monitor you more closely, and your dosing may be individualized. Expect checks for bleeding, including surgical wound drainage if you've had surgery. Blood tests, including clotting tests and hemoglobin levels, may be done periodically. A drop in blood pressure or h… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Heparin and Tenecteplase Interaction

Ask in your own words about taking Heparin and Tenecteplase together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (5)

  1. Product Information: ANGIOMAX(R) IV injection, bivalirudin IV injection. The Medicines Company, Parsippany, NJ, 2005.
  2. Product Information: Iprivask(TM), desirudin for injection. Aventis Pharmaceuticals Inc. Bridgewater, NJ, 2003.
  3. Product Information: Xarelto(R) oral film-coated tablets, rivaroxaban oral film-coated tablets. Bayer HealthCare (per manufacturer), Leverkusen, Germany, 2008. DailyMed
  4. Jarvinen P, Aromaa U, Roiha M, et al: Streptokinase and concomitant oral anticoagulants in the treatment of deep venous thrombosis. Klin Wochenschr 1978; 56:801-804. PubMed
  5. Mazya MV, Lees KR, Markus R, et al: Safety of intravenous thrombolysis for ischemic stroke in patients treated with warfarin. Ann Neurol 2013; 74(2):266-274. PubMed
Was this write-up helpful?

Other Serious Interactions of Heparin and Tenecteplase

Also serious with Heparin

Also serious with Tenecteplase

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Heparin

With Tenecteplase

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.